Federal News

Displaying results 1-10 (of 53)
 |<  < 1 2 3 4 5 6  >  >| 

Formulary Changes Hurt the Patients Most

Rheumatologists are at the forefront of innovative treatments for patients with complex autoimmune diseases such as rheumatoid arthritis.

READ MORE

New Legislation Could Shine a Light on the Elusive World of Prescription Drug Pricing

Ever-increasing drug prices have recently been at the forefront of the healthcare debate in America, and a new bill introduced in Congress last week may be the important first step in shedding light on the intermediaries who play a huge yet largely unnoticed role in drug pricing: Pharmacy Benefit Managers (PBMs).

READ MORE

CSRO Submits Interchangeability Comments to FDA

As patient and physician advocates, we have been deeply involved in the debate surrounding implementation of the Biologics Price Competition and Innovation Act (BPCIA).

READ MORE

Advocating for Your Patients and Your Practice

Government regulations are constantly felt within the healthcare industry, and more specifically within rheumatology, so it is important to remember that advocating on behalf of one’s own practice is proactive towards the needs of the physician, and ultimately the patient.

READ MORE

FDA Finalizes Standard for Non-Proprietary Naming of Biologics and Biosimilars

The FDA announced the release of the final guidance on the “Nonproprietary Naming of Biological Products.”

READ MORE

MACs Continue Efforts to Downcode Cimzia and Other Biologics

Concern among the rheumatology community continues to mount over growing efforts by various Medicare Administrative Contractors (MACs) to downcode the administration coding for certain biologics from complex to simple.

READ MORE

Legislation Emerges to Replace Obamacare

Congressional Republicans have offered a bill called the American Health Care Reform Act of 2017 to replace Obamacare, and the sponsoring legislators believe it could put patients and doctors more in charge of their healthcare decisions.

READ MORE

Obama Administration Withdraws Medicare Part B Demonstration Project

The Obama Administration announced it will withdraw its planned nationwide experiment in which Medicare would have reduced payments for many drugs given to patients in doctors’ offices and hospital clinics.

READ MORE

21st Century Cures — Comparison of Package to House-Passed Bill (HR 6)

This week, the House is expected to vote on the "21st Century Cures Act," legislation intended to increase patients' access to life saving treatments. The CSRO has provided the attached document for your review which provides an overview of the changes the 2016 legislation will make to the House passed 2015 bill.

READ MORE

Post-Election Analysis and Outlook for the 115th Congress

The CSRO would like to provide rheumatology advocates with the below document that includes key post election information on expected changes to House and Senate committees and leadership, as well as information released by the Trump Transition team related to their healthcare priorities.

READ MORE

Displaying results 1-10 (of 53)
 |<  < 1 2 3 4 5 6  >  >|